Women's Health Study: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz No edit summary |
mNo edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 5: | Line 5: | ||
==References== | ==References== | ||
{{reflist}} | |||
[[Category:Suggestion Bot Tag]] | |||
Latest revision as of 07:00, 9 November 2024
The Women's Health Study is a randomized controlled trial whose purpose is "to evaluate the effects of vitamin E and low-dose aspirin in primary prevention of cardiovascular disease and cancer in apparently healthy women."[1] The trial is sponsored by the Unites States National Heart, Lung, and Blood Institute (NHLBI) under the National Institutes of Health/.
Publications from the trial are listed at http://clinicaltrials.gov/ct2/show/NCT00000479.
References
- ↑ Anonymous. " Women's Health Study (WHS): A Randomized Trial of Low-Dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer. ClinicalTrials.gov. Retrieved on 2009-02-10.